Powering Alpha Therapy: Actinium‑225 from Thorium‑229 Generator, Traditional Route Explained
Introduction Ac-225 is an α-emitting radionuclide with a half-life of 9.9 days. Its high energy, multi-day half-life and short travel distance in tissues makes it an attractive radioisotope for targeted